Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Oxcarbazepine

An antiepileptic derived from carbamazepine, approved in Denmark in 1990 and in the United States in 2000; it is used to treat focal seizures in epilepsy. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?It is a prodrug: in the body it is converted into its 10-hydroxy metabolite (MHD, also called licarbazepine), which is the real active form.

OxcarbazepineGo to the active ingredient →
OxcarbazepineActive ingredientOxcarbazepineCat. No. P-O053-001CAS 28721-07-5

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.